Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: Inappropriate test substance (mixture of 4,4'- Diaminodiphenylmethane and higher oligomers were tested)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1973

Materials and methods

Principles of method if other than guideline:
BASF-Test: The substance was injected into the peritoneal cavity. Young adult laboratory mice were purchased from breeder. Usually the source and strain of animals were not documented. Several groups of 5 mice per sex and dose were treated simultaneously with preparations of the test substance in suitable vehicle. The concentrations of these preparations were used to achieve comparable volumes per kg body weight. Group-wise documentation of clinical signs was performed over the 14- days study period.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Reference substance name:
Automatically generated during migration to IUCLID 6, no data available
IUPAC Name:
Automatically generated during migration to IUCLID 6, no data available
Details on test material:
- Name of test material (as cited in study report): MDA (auch polyamin genannt)
- Physical state: liquid
- Composition of test material, percentage of components: mixture of 4,4'-methylenedianiline (also known as phenylbase) isomers and higher oligomers

Test animals

Species:
mouse
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- body weight at study initiation:
200 mg/kg bw: male 24-31 g, female 21-25 g
400 mg/kg bw: male 30-34 g, female 22-25 g
500 mg/kg bw: male 24-26 g, female 20-24 g
640 mg/kg bw: male 23-26 g, female 22-25 g
800 mg/kg bw: male 27-31 g, female 22-24 g
1600 mg/kg bw: male 18-32 g, female 22-28 g

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
CMC (carboxymethyl cellulose)
Details on exposure:
DOSAGE PREPARATION:
- Stock solutions prepared:
2 % for 200 mg/kg bw dose group,
4 % for 400 and 500 mg/kg bw dose group,
8 % for 640 and 800 mg/kg bw dose groups, and
16 % for 1600 mg/kg bw dose group.
Doses:
200, 400, 500, 640, 800 and 1600 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: mortality and clinical signs of toxicity were observed several times on the application day and thereafter once each working day, body weights were only recorded at the beginning of the study.
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
500 mg/kg bw
Mortality:
see free text
Clinical signs:
Shortly after injection, tremor, partly dyspnea and intermittent respiration were observed. Few moments later, abdominal position, irregular respiration, apathy were observed. In the following days, the symptoms were weaker and no symptoms were observed 4 days after injection.
Gross pathology:
substance deposits in the intraabdominal cavity, hypertrophy of liver and kidney

Any other information on results incl. tables

Dose (mg/kg bw)

Sex

Mortality in

1 h

24 h

48 h

7 days

14 days

1600

Male

0/5

5/5

5/5

5/5

 

Female

0/5

5/5

5/5

5/5

 

800

Male

0/5

3/5

4/5

4/5

4/5

Female

0/5

4/5

4/5

4/5

4/5

640

Male

0/5

0/5

0/5

2/5

2/5

Female

0/5

0/5

5/5

5/5

5/5

500

Male

0/5

0/5

0/5

0/5

0/5

Female

0/5

0/5

2/5

5/5

5/5

400

Male

0/5

0/5

0/5

0/5

0/5

Female

0/5

0/5

0/5

1/5

1/5

200

Male

0/5

0/5

0/5

0/5

0/5

Female

0/5

0/5

0/5

0/5

0/5

Applicant's summary and conclusion